Le Lézard
Classified in: Health
Subjects: PER, ANW

GREY WOLF ANIMAL HEALTH ANNOUNCES ANNUAL AND SPECIAL MEETING VOTING RESULTS


TORONTO, June 22, 2023 /CNW/ - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, announced today the voting results from the Company's annual and special meeting of the shareholders held on June 21, 2023 (the "Meeting").

The results of the director elections are as follows:

Director Nominee

Outcome

Votes For

% For

Votes Withheld

% Withheld

Jill Angevine

Elected

9,409,968

99.894

10,000

0.106

Shawn Aspden

Elected

9,409,968

96.072

370,000

3.928

Diane Bourassa

Elected

9,409,968

99.894

10,000

0.106

Robert Harris

Elected

9,409,968

99.894

10,000

0.106

Dr. Ian Sandler

Elected

9,409,968

99.894

10,000

0.106


The shareholders of the Company also voted: (i) to re-appoint PricewaterhouseCoopers LLP, as auditors of the Company for the ensuing year and to authorize the directors to determine their remuneration,  (ii) to approve the Company's amended and restated stock option plan in the form attached as Schedule "A" to the management information circular dated May 9, 2023 prepared in connection with the Meeting (the "Information Circular"), and (iii) to approve the Company's Advance Notice By-law in the form attached as Schedule "B" to the Information Circular.

About Grey Wolf Animal Health Corp.?

Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified animal health ?company founded by a veterinarian to bring to market a broad portfolio of products that meets the ?unmet needs of veterinarians, clinics and pets.  The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel ?in Canada. For additional information, please visit: www.greywolfah.com.?

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Grey Wolf Animal Health Corp.


These press releases may also interest you

at 16:35
Nabla Bio (aka "Nabla"), pioneers in generative protein design, today announced the close of a $26 million Series A financing, led by Radical Ventures with participation from all existing investors, and strategic collaborations with AstraZeneca,...

at 16:30
With tremendous support from Canada's seven National Hockey League (NHL) teams, individuals and several communities, the ALS Super Fund has achieved a significant milestone: surpassing its first $1 million in donations through Charitable Impact's...

at 16:30
Perimeter Medical Imaging AI, Inc. ("Perimeter" or the "Company") ? a commercial-stage medical technology company ? today reported financial results for its first quarter ended March 31, 2024 and provided a corporate update. Adrian Mendes,...

at 16:30
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the First Quarter ended March 31, 2024 and provided a corporate...

at 16:30
Nanopharmaceutics, Inc. , a clinical-stage pharmaceutical development company, announced the initiation of a Phase I clinical study with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University "A Phase 1 Adaptive Dose Escalation...

at 16:10
DermTech, Inc. (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today reported its first-quarter 2024 financial results. First-Quarter 2024 Financial Results Billable sample volume...



News published on and distributed by: